APA (7th ed.) Citation

SL, W., D, M., & M, K. (2022). CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome. Clinical and experimental dermatology, 47(12), 2284. https://doi.org/10.1111/ced.15354

Chicago Style (17th ed.) Citation

SL, Wong, Martiniuc D, and Kiuru M. "CDKN2A Exon 1B Deletion Predisposing to Melanoma and Neural System Tumour Syndrome." Clinical and Experimental Dermatology 47, no. 12 (2022): 2284. https://doi.org/10.1111/ced.15354.

MLA (9th ed.) Citation

SL, Wong, et al. "CDKN2A Exon 1B Deletion Predisposing to Melanoma and Neural System Tumour Syndrome." Clinical and Experimental Dermatology, vol. 47, no. 12, 2022, p. 2284, https://doi.org/10.1111/ced.15354.